Lung Cancer Risk in Patients By Taking This Thyroid Drug

Lung Cancer Risk in Patients By Taking This Thyroid Drug

A new study has uncovered a link between the synthetic thyroid hormone (trade name Methimazole) used to treat millions diagnosed with Thyroid Diseases, bringing to the forefront the harmful role that over diagnosis and over treatment plays in nutritional deficiency and chemical exposure related ‘diseases.’A new Italian study published in the journal Reproductive Biology and Endocrinologytitled, “Methimazole and lung cancer in females: the importance of oxidative stress,” has raised a concerning possibility:

Methimazole (T4), one of the world’s most commonly prescribed forms of hormone replacement, may be raising the risk of lung cancer in millions of men and women being treated for Thyroid Diseases.The authors of the study pointed out that Methimazole (T4) treatment can lead to medication-induced (iatrogenic) thyroid over-activity (hyperthyroidism) and oxidative stress that can lead to a significant patient discomfort. They also noted that oxidative stress is one of the causes of chronic diseases and cancer.


Please enter your comment!
Please enter your name here